Automated insulin delivery for newly diagnosed type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study is testing whether an automated insulin delivery system (often called an artificial pancreas) can help adults who have just been diagnosed with type 1 diabetes manage their blood sugar levels. It aims to improve long-term control and make day-to-day management easier.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have been recently diagnosed with type 1 diabetes.
- A blood test must show that you have type 1 diabetes antibodies (autoantibodies positive).
- You cannot be pregnant.
- You cannot have cancer or other serious health conditions that would make it hard to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether starting an automated insulin delivery (AID) system soon after a type 1 diabetes diagnosis helps improve blood sugar control and reduces future health problems. The AID system combines a pump and continuous glucose monitor to automatically adjust insulin.
This study tests an early use of an automated insulin delivery system for people recently diagnosed with type 1 diabetes. The goal is to see if starting this technology soon after diagnosis helps with blood sugar control and quality of life.
This study tests a system that measures blood sugar and automatically adjusts insulin delivery. It is for adults with type 1 diabetes who use insulin injections or a pump.
This study tests an automated insulin pump system that adjusts insulin delivery to help keep blood sugar levels stable during pregnancy. It may reduce the burden of managing type 1 diabetes and improve outcomes for you and your baby.
This study tests an “artificial pancreas” system that automatically helps control insulin to reduce wide swings in blood sugar. It also aims to see whether steadier sugars can improve heart health in adults with type 1 diabetes.
This study tests a smart insulin pump system that adjusts automatically during exercise. It aims to make managing blood sugar easier and safer.
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.